NO137754C - Analogifremgangsmaate for fremstilling av terapeutisk aktive steroidforbindelser - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive steroidforbindelser

Info

Publication number
NO137754C
NO137754C NO2406/72A NO240672A NO137754C NO 137754 C NO137754 C NO 137754C NO 2406/72 A NO2406/72 A NO 2406/72A NO 240672 A NO240672 A NO 240672A NO 137754 C NO137754 C NO 137754C
Authority
NO
Norway
Prior art keywords
therapeutically active
steroid compounds
active steroid
preparing therapeutically
analogical procedure
Prior art date
Application number
NO2406/72A
Other languages
English (en)
Norwegian (no)
Other versions
NO137754B (no
Inventor
Gordon Hanley Phillipps
Alan Frederick English
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of NO137754B publication Critical patent/NO137754B/no
Publication of NO137754C publication Critical patent/NO137754C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO2406/72A 1971-07-05 1972-07-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive steroidforbindelser NO137754C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3134971A GB1391443A (en) 1971-07-05 1971-07-05 Ester of betamethasone and its 9alpha-chloro analogue

Publications (2)

Publication Number Publication Date
NO137754B NO137754B (no) 1978-01-09
NO137754C true NO137754C (no) 1978-04-19

Family

ID=10321802

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2406/72A NO137754C (no) 1971-07-05 1972-07-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive steroidforbindelser

Country Status (17)

Country Link
JP (1) JPS5644079B1 (fr)
AR (2) AR194120A1 (fr)
AU (1) AU464251B2 (fr)
BE (1) BE785812A (fr)
CA (1) CA983919A (fr)
CH (1) CH609065A5 (fr)
DE (1) DE2232827A1 (fr)
DK (1) DK131474B (fr)
FR (1) FR2144761B1 (fr)
GB (1) GB1391443A (fr)
IE (1) IE36529B1 (fr)
IL (1) IL39821A (fr)
NL (1) NL169882C (fr)
NO (1) NO137754C (fr)
PH (1) PH13195A (fr)
SE (1) SE385904B (fr)
ZA (1) ZA724598B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5024427A (fr) * 1973-01-03 1975-03-15
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
JPS6163976U (fr) * 1984-10-01 1986-05-01
KR101591482B1 (ko) 2008-05-28 2016-02-03 레베라겐 바이오파마 인코포레이티드 질환의 치료를 위한 NF-κB 의 비호르몬성 스테로이드 조절제
EP2556083A4 (fr) 2010-04-05 2013-12-04 Validus Biopharma Inc Modulateurs stéroïdes non hormonaux de nf- kappa b pour le traitement de maladies
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Also Published As

Publication number Publication date
IL39821A (en) 1976-02-29
IE36529B1 (en) 1976-11-24
FR2144761B1 (fr) 1976-03-05
FR2144761A1 (fr) 1973-02-16
SE385904B (sv) 1976-07-26
BE785812A (fr) 1973-01-04
NL169882B (nl) 1982-04-01
AU4420572A (en) 1974-01-10
DE2232827A1 (de) 1973-01-18
AR194120A1 (es) 1973-06-22
DK131474B (da) 1975-07-21
NL7209345A (fr) 1973-01-09
JPS5644079B1 (fr) 1981-10-16
ZA724598B (en) 1973-03-28
AR194553A1 (es) 1973-07-23
IL39821A0 (en) 1972-09-28
NO137754B (no) 1978-01-09
DK131474C (fr) 1975-12-08
IE36529L (en) 1973-01-05
GB1391443A (en) 1975-04-23
CA983919A (en) 1976-02-17
NL169882C (nl) 1982-09-01
PH13195A (en) 1980-01-18
AU464251B2 (en) 1975-08-21
CH609065A5 (en) 1979-02-15

Similar Documents

Publication Publication Date Title
NO138805C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive triazolforbindelser
NO137440C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pleuromutiliner
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO136045C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazinoner.
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO139127C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylalkylaminer
NO136251C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater.
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO140596C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktive hydroksyalkylxantiner
NO137754C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive steroidforbindelser
NO137151C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive ortiotropin-peptider
FI49827C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-hydroksimetyy li-isokinoliinien valmistamiseksi.
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO138251C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer
NO138375C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme cefalosporinderivater
SE385706B (sv) Forfarande for framstellning av terapeutiskt aktiva linkomycinanaloger
NO139733C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av metylamin
NO140299C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner
NO137695C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser
NO137727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener
NO137696C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepin-derivater
SE386438B (sv) Forfarande for framstellning av terapeutiskt aktiva derivat av 3-metylamino-tetrahydrokarbazoler innehallande fluor
NO136841C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylimidazolidinoner
NO137893C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-m-trifluormetylfenyl-2-cyanoalkylaminopropaner